Advanced Clinical Seminars

Sunday 06 May
Debate: Evidence-based CVD prevention in diabetes today

Chair:
  • Marja-Riitta Taskinen

Should the main target be hyperglycaemia or should we focus on other risk-factors?

Lars Rydén, Stockholm, Sweden

Naveed A. Sattar, Glasgow, United Kingdom

Sunday 06 May
Life after acute coronary syndromes: Can we prevent further events?

Is it possible to prevent recurrent events?

Ulf Landmesser, Berlin, Germany

LDL after ACS: How low to go? How to go there?

José L. Zamorano, Madrid, Spain

Reality check: Guidelines versus real life after ACS

Fausto J. Pinto, Lisbon, Portugal

Monday 07 May
From imaging studies - What is meant by significant atherosclerosis?

Defining high risk plaque by IVUS and OCT

Stephen Nicholls, Adelaide, Australia

Can CT determine who is at highest risk?

Jeroen J. Bax, Leiden, The Netherlands

Multimodality imaging is the way to go

Lale Tokgozoglu, Ankara, Turkey

Tuesday 08 May
Guidelines in reality - questions raised by the guidelines (four cases)

Familial Hypercholesterolaemia

Kausik Ray, London, United Kingdom

Familial chylomicronemia syndrome (FCS)

Maurizio Averna, Palermo, Italy

Primary prevention of CVD

Guy G. De Backer, Ghent, Belgium

Very high risk patient - secondary treatment

Erik S. Stroes, Amsterdam, The Netherlands